Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 867321, 4 pages
http://dx.doi.org/10.1155/2014/867321
Research Article

LRRK2 G2385R and R1628P Mutations Are Associated with an Increased Risk of Parkinson’s Disease in the Malaysian Population

1Department of Biomedical Science, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
2Divisions of Neurology and Nephrology, Department of Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
3Department of Neurology, Hospital Pulau Pinang, 10990 Penang, Malaysia
4Division of Neurology, Department of Medicine, Hospital Universiti Kebangsaan Malaysia, 56000 Kuala Lumpur, Malaysia
5Division of Neurology, Department of Medicine, Hospital Sultanah Nur Zahirah, 20400 Kuala Terengganu, Malaysia
6Department of Neurology, Hospital Kuala Lumpur, 50586 Kuala Lumpur, Malaysia
7Department of Medicine, Hospital Seberang Jaya, 13700 Penang, Malaysia
8Department of Clinical Research and Neurology, Singapore General Hospital, Singapore 169608

Received 23 May 2014; Accepted 24 July 2014; Published 28 August 2014

Academic Editor: Hiroyuki Tomiyama

Copyright © 2014 Aroma Agape Gopalai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. R. Dorsey, R. Constantinescu, J. P. Thompson et al., “Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030,” Neurology, vol. 68, no. 5, pp. 384–386, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Lee, Y. Bordelon, J. Bronstein, and B. Ritz, “Traumatic brain injury, paraquat exposure, and their relationship to Parkinson disease,” Neurology, vol. 79, no. 20, pp. 2061–2066, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. L. M. Bekris, F. M. Ignacio, and C. P. Zabetian, “The genetics of Parkinson disease,” Journal of Geriatric Psychiatry and Neurology, vol. 23, no. 4, pp. 228–242, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Satake, Y. Nakabayashi, I. Mizuta et al., “Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease,” Nature Genetics, vol. 41, no. 12, pp. 1303–1307, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. L. J. Ozelius, G. Senthil, R. Saunders-Pullman et al., “LRRK2 G2019S as a cause of Parkinson’s disease in Ashkenazi Jews,” New England Journal of Medicine, vol. 354, no. 4, pp. 424–425, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. E. K. Tan, H. Shen, L. C. S. Tan et al., “The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients,” Neuroscience Letters, vol. 384, no. 3, pp. 327–329, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. C. P. Zabetian, M. Yamamoto, A. N. Lopez et al., “LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease,” Movement Disorders, vol. 24, no. 7, pp. 1034–1041, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Toft, K. Haugarvoll, O. A. Ross, M. J. Farrer, and J. O. Aasly, “LRRK2 and Parkinson's disease in Norway,” Acta Neurologica Scandinavica, vol. 115, no. 187, pp. 72–75, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Di Fonzo, Y. H. Wu-Chou, C. S. Lu et al., “A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan,” Neurogenetics, vol. 7, no. 3, pp. 133–138, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Funayama, Y. Li, H. Tomiyama et al., “Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population,” NeuroReport, vol. 18, no. 3, pp. 273–275, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. X.-K. An, R. Peng, T. Li et al., “LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China,” European Journal of Neurology, vol. 15, no. 3, pp. 301–305, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Kim, J. Y. Lee, H. J. Kim et al., “The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population,” Parkinsonism and Related Disorders, vol. 16, no. 2, pp. 85–88, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. O. A. Ross, Y. Wu, M. Lee et al., “Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease,” Annals of Neurology, vol. 64, no. 1, pp. 88–92, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. E. K. Tan, Y. Zhao, L. Skipper et al., “The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence,” Human Genetics, vol. 120, no. 6, pp. 857–863, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. I. F. Mata, J. M. Kachergus, J. P. Taylor et al., “Lrrk2 pathogenic substitutions in Parkinson's disease,” Neurogenetics, vol. 6, no. 4, pp. 171–177, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. E. K. Tan, L. C. Tan, H. Q. Lim et al., “LRRK2 R1628P increases risk of Parkinson's disease: replication evidence,” Human Genetics, vol. 124, no. 3, pp. 287–288, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Pulkes, C. Papsing, S. Mahasirimongkol, M. Busabaratana, K. Kulkantrakorn, and S. Tiamkao, “Frequencies of LRRK2 variants in Thai patients with Parkinson's disease: evidence for an R1628P founder,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 82, no. 10, pp. 1179–1180, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Lu, Y. Wu-Chou, M. Van Doeselaar et al., “The LRRK2 Arg1628Pro variant is a risk factor for Parkinson's disease in the Chinese population,” Neurogenetics, vol. 9, no. 4, pp. 271–276, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. O. A. Ross, A. I. Soto-Ortolaza, M. J. Heckman et al., “Association of LRRK2 exonic variants with susceptibility to Parkinsons disease: a casecontrol study,” Lancet Neurology, vol. 10, pp. 898–908, 2011. View at Google Scholar
  20. H. C. Fung, C. M. Chen, J. Hardy, A. B. Singleton, and Y. R. Wu, “A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan,” BMC Neurology, vol. 6, article 47, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. M. J. Farrer, J. T. Stone, C. Lin et al., “Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia,” Parkinsonism and Related Disorders, vol. 13, no. 2, pp. 89–92, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Miyake, Y. Tsuboi, M. Koyanagi et al., “LRRK2 Gly2385Arg polymorphism, cigarette smoking, and risk of sporadic Parkinson's disease: a case-control study in Japan,” Journal of the Neurological Sciences, vol. 297, no. 1-2, pp. 15–18, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Tan, M. Tang, L. C. Tan et al., “Lrrk2 R1628P in non-Chinese Asian races,” Annals of Neurology, vol. 64, no. 4, pp. 472–473, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Yu, F. Hu, X. Zou et al., “LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China,” Brain Research, vol. 1296, pp. 113–116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Zhang, J. Burgunder, X. An et al., “LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China,” Movement Disorders, vol. 24, no. 13, pp. 1902–1905, 2009. View at Publisher · View at Google Scholar · View at Scopus